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A B S T R A C T
Purpose: Cortico-amygdalohippocampectomy (CAH) has become an important treatment option for
patients with refractory temporal lobe epilepsy and mesial temporal sclerosis (TLE-MTS); it has resulted
in a 60–70% seizure remission rate and signiﬁcant quality of life (QOL) improvements. Video-
electroencephalography (VEEG) monitoring has been widely used in epilepsy centers for pre-surgical
evaluation. A major concern in epilepsy surgery is whether to consider CAH treatment in patients with
psychosis of epilepsy (POE). This study analyzed the safety and adverse events (AEs) of VEEG monitoring
and the post-surgical outcomes of patients with refractory TLE-MTS and POE who underwent CAH.
Method: Clinical, sociodemographic and VEEG data from 18 patients with TLE-MTS and POE were
analyzed. Psychiatric evaluations were performed using DSM-IV and ILAE criteria. The seizure outcome
was evaluated using Engel’s criteria.
Results: Two patients (11.2%) presented AEs that did not result in increased lengths of hospitalization. Of
the 10 patients (55.5%) who underwent CAH, 6 (60%) became free of disabling seizures (Engel I). The
psychiatric and QOL evaluations revealed improvements of psychotic symptoms (p = 0.01) and in
Physical Health (p = 0.01) following surgery.
Conclusion: These data reinforce that VEEG monitoring is a safe method to evaluate patients with
refractory TLE-MTS and POE in epilepsy centers.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
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Epilepsy surgery has become an important treatment option for
patients with refractory temporal lobe epilepsy (TLE); current
evidence suggests a 60–70% remission rate for long-term epileptic
symptoms and signiﬁcant improvements in quality of life (QOL).1,2
Data from previous studies have demonstrated that cortico-
amygdalohippocampectomy (CAH) is a safe, efﬁcient surgical
procedure for patients with refractory TLE and mesial temporal
sclerosis (TLE-MTS); the latter condition compromises the primary
structures of the limbic system, particularly the hippocampus and
amygdala. TLE-MTS is also one of the most common types of
surgically remediable epileptic syndromes.3–5 Prolonged video-
electroencephalography (VEEG) monitoring has been widely used
in specialized epilepsy centers for pre-surgical evaluation.6* Corresponding author at: Rua Botucatu, 740, Vila Clementino, Sa˜o Paulo, SP,
CEP: 04023-900, Brazil. Fax: +55 11 5549 3819.
E-mail address: ﬁlho.gerardo@gmail.com (G.M. de Araujo Filho).
1059-1311/$ – see front matter  2012 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2012.06.002One of the major decisions in epilepsy surgery is whether to
operate on subjects who have previous histories of psychosis of
epilepsy (POE). Many epilepsy centers exclude psychotic patients
from their surgical programs due to the possibility of alternative
psychosis, postoperative exacerbations of preexisting psychosis
and the occurrence of postictal disorders during VEEG, which is
facilitated by the reduction of antiepileptic drugs. In addition, few
studies have addressed the psychiatric and seizure post-surgical
outcomes of patients with refractory epilepsy and pre-surgical
psychoses.7,8 The purpose of this study was to analyze the safety
and adverse events (AEs) during VEEG monitoring and the surgical,
psychiatric and QOL outcomes of patients with refractory TLE-MTS
and a previous history of POE.
2. Methods
2.1. Subjects
One hundred forty-ﬁve TLE-MTS patients were followed in the
outpatient clinic of a tertiary center (Epilepsy Section of the
Universidade Federal de Sa˜o Paulo, Sa˜o Paulo, Brazil) from Januaryvier Ltd. All rights reserved.
P.O. da Conceic¸a˜o et al. / Seizure 21 (2012) 583–5875842002 to December 2011. All of the patients had submitted to VEEG
monitoring and a psychiatric evaluation. After written informed
consent was obtained, 18 TLE-MTS patients with a previous history
of POE (12.4%) were included in the study. To be included, the
patients required an electroclinical diagnosis of refractory TLE-
MTS and POE, which was based on the Diagnostic and Statistical
Manual for mental disorders, 4th edition (DSM-IV) and Interna-
tional League Against Epilepsy (ILAE) classiﬁcations9,10 and an age
of at least 16 years. All 18 patients were followed for at least two
years, and they had clear MRI ﬁndings consistent with unilateral or
bilateral MTS and concordant interictal and ictal EEG data. Patients
were excluded if they suffered from other neurological diseases in
addition to epilepsy, cognitive impairments precluding psychiatric
and clinical evaluations, or were younger than 16 years old.
2.2. Procedures
The patients were subjected to 2–6 days of continuous video-
electroencephalographic (VEEG) monitoring with 32-channel EEG
recording. Electrodes were placed on the temporal lobe according
to the 10–10 system, including the sphenoidal position. MTS was
deﬁned if atrophy, increased T2-weighted signal, decreased T1-
weighted signal, and/or a disrupted internal hippocampal struc-
ture were present and accompanied by atrophy of the amygdala
and/or temporal pole signal alteration upon visual inspection of
the MRI pictures. The epileptogenic zone was determined by
predominantly ipsilateral interictal epileptiform discharges (80%
cutoff) and by seizure onset that was recorded during prolonged
VEEG monitoring. Epilepsy was considered to be resistant to
medical treatment when the seizures persisted after the utilization
of at least two ﬁrst-line medications for partial seizures at the
highest tolerated doses. Initial precipitant injury (IPI) was deﬁned
as the occurrence of severe cerebral events in the ﬁrst year of life
before the appearance of epilepsy that required medical interven-
tion and/or hospitalization; such events included febrile seizures,
meningoencephalitis, head trauma or severe perinatal hypoxia.
The withdrawal of AEDs was made during the ﬁrst three days at the
hospital, and the patients were observed for 24 h each day via
monitoring screens that were located outside the monitoring
room; the patients were monitored by two EEG-monitoring
technicians and a specialized epileptologist who was on call for
24 h. Adverse events (AEs) were deﬁned as falls, fractures, status
epilepticus (SE), PIP, suicide attempts, and deep venous thrombosis
during VEEG monitoring. PIP was considered an adverse event if it
occurred within 7 days of the admission date. The Epilepsy Surgery
Inventory (ESI-55)11 was used to evaluate the patients’ QOL before
and after surgery.
2.3. Psychiatric evaluation
A single psychiatrist (GMAF) conducted the clinical interviews
using the DSM-IV axis I and ILAE criteria.10,12–14 IIP was deﬁned as
a chronic psychotic state that often included an insidious onset of
paranoid delusions and hallucinations that may be present in
clear consciousness and not temporally related to seizures. PIP
was deﬁned as episodes of psychosis within 1 week after a
seizure(s), psychosis lasting >15 h and <3 months, delusions,
hallucinations in clear consciousness, bizarre or disorganized
behavior, formal thought disorder, or affective changes, with no
evidence of antiepileptic drug (AED) toxicity, non-convulsive
status epilepticus, recent head trauma, alcohol and/or drug
intoxication/withdrawal, or prior chronic psychotic disorder.13,14
Information regarding the family history of epilepsy and PD was
obtained from the patients through broad questions that asked
whether any ﬁrst-degree relative was receiving treatment either
for epilepsy or for any PD at the moment of the clinical interview.The psychiatric evaluations occurred pre-surgically and were
then held every three months by the same psychiatrist (GMAF).
The Brazilian version of the Brief Psychiatric Rating Scale
anchored (BPRS-A)15 was also used to measure the severity of
psychotic symptoms before and after surgery, and the scores that
were used for the statistical analysis were obtained at one and two
years after surgery.
2.4. Surgery and post-surgical evaluation
After the VEEG evaluation, the patients without a surgical
indication were followed at three-month intervals by the same
neurologist, and the patients with a surgical indication underwent
CAH within 2 months of the initial evaluation. The surgical
procedure consisted of en block resectioning of the superior,
middle, inferior temporal and fusiform gyri, with a posterior limit
of 4.5 cm from the tip of the temporal lobe. After opening the
temporal horn, the mesial temporal structures (hippocampus,
amygdala and parahippocampal gyrus) were also resected.3 The
patients were evaluated one, three, six and 12 months after surgery
and then every six months by two neurosurgeons. Engel’s
classiﬁcation system was utilized to measure the patients’ seizure
outcomes one and two years after the surgery.16 The QOL of all of
the patients submitted to CAH was also evaluated after the ﬁrst and
second years after surgery.
2.5. Statistical analysis
The statistical analyses were performed using the version 10.0
of Statistical Package for Social Sciences (SPSS 10.0, Chicago,
Illinois). Some socio-demographic characteristics were presented
as one-sample proportions that included conﬁdence intervals. The
McNemar and Wilcoxon tests were used to analyze the clinical and
socio-demographic data, and corrections were used for the
multiple statistical comparisons. p values of <0.05 were consid-
ered to be statistically signiﬁcant.
3. Results
The data from 18 patients (12 women, 6 men, mean age of 40.4
years, standard deviation [SD] = 8.97, range of 26–65 years, mean
of duration of epilepsy of 29.7 years, SD = 11.13) were analyzed.
The mean length of the VEEG monitoring was 94 h. Nine patients
(50%) presented with left-sided MTS, eight (44.4%) were right-
sided and one (5.6%) had bilateral MTS. Three patients (16.8%) had
a positive psychiatric family history, while four (22.2%) had a
positive psychic aura history, and eight (44.4%) had an IPI in their
epilepsy history. The patients’ clinical and sociodemographic
characteristics are summarized in Table 1.
Regarding the psychiatric evaluations, according to the ILAE
criteria,10 ten patients (55.5%) had a diagnosis of IIP, and eight
patients (45.5%) had a diagnosis of PIP. All of the patients with IIP
also presented with the diagnosis of paranoid schizophrenia
according to the DSM-IV criteria.12 All of the patients were taking
one antipsychotic drug; Risperidone (RIS) was the most common
drug (ten patients), which was followed by Haloperidol (HAL) (ﬁve
patients) and Olanzapine (OLZ) (three patients). The mean pre-
surgical doses of RIS, HAL and OLZ were 3 mg/day, 7.5 mg/day and
10 mg/day, respectively, and the doses did not differ signiﬁcantly
between the PIP and IIP patients (p = 0.89).
During the VEEG monitoring process, none of the patients had a
cluster of seizures. Two patients (11.2%) presented with one
episode of PIP as an AE, and these AEs were associated with more
than 100 tonic–clonic seizures during the patients’ lives and with
the patients’ previous PIP histories. No other AEs were recorded.
The age of epilepsy onset, duration of epilepsy, mean length of
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P.O. da Conceic¸a˜o et al. / Seizure 21 (2012) 583–587 585VEEG monitoring, and lateralized EEG or MRI asymmetries were
not associated with the AEs.
Ten patients (55.5%) underwent CAH; ﬁve patients had PIP and
ﬁve had IIP. After two years of post-surgical follow-up, six of the
patients (60%) were free of disabling seizures (Engel Class I), three
(30%) had rare disabling seizures (Engel Class II), and one presented
with a worthwhile seizure improvement (Engel Class III) (Fig. 1).
The differences in the post-surgical outcomes between the ﬁrst and
second year were not signiﬁcant (p = 1.00). Antipsychotic drugs
were discontinued in all ﬁve CAH patients with PIP because they
presented with a complete remission of psychotic symptoms after
surgery and lacked any recurrence within two years of follow-up. A
reduction of the mean antipsychotic doses was observed in the IIP
patients after surgery (2 mg/day for RIS and 5 mg/day for HAL), but
performing statistical comparisons of the patients who did not
undergo surgery was unfeasible due to the reduced number of
subjects involved. Among the patients who underwent CAH, a
mean BPRS-A score of 39.9  5.36 (range 26–44) was observed pre-
surgically; this score was reduced to 26.7  6.21 (range 18–36) in the
ﬁrst year and to 22.3  4.47 (range 18–32) in the second year after
surgery. A signiﬁcant difference was observed between the pre-
surgical and ﬁrst-year scores (p = 0.012), but no differences were
observed between the PIP and IIP patients (p = 0.87).
The ESI-55 was used to measure the patients’ QOL before and
after surgery. Although QOL improvements were observed in all of
the patients’ domains after surgery (Fig. 2), signiﬁcant differences
were observed only in the physical health sphere (p = 0.01). The p-
value was approximately 0.05 in the overall quality of life (p = 0.07)
and psychosocial health (p = 0.12) spheres, and it was not
signiﬁcant in the cognitive and functional sphere (p = 0.23).
4. Discussion
The data from previous studies have demonstrated that 30–40%
of patients with epilepsy present with a medically intractable
disease with available AEDs. CAH is a safe, efﬁcient surgical
procedure for patients with refractory TLE-MTS, which is one of the
most common types of surgically remediable epileptic syndromes;
it confers an approximately 70% chance of long-term seizure
freedom.3–5 However, one of the most important decisions in
epilepsy surgery is whether to operate on patients with a previous
history of POE. The prevalence of psychoses in hospital-basedFig. 1. Engel and ILAE classiﬁcations one and two years after epilepsy surgery of
patients with mesial temporal sclerosis and psychoses of epilepsy.
Fig. 2. Median scores of ESI-55 spheres before, after one and two years of epilepsy
surgery in patients with mesial temporal sclerosis and psychoses of epilepsy. PHS,
physical health sphere; PSHS, psychosocial health sphere; CFS, cognitive and
functional sphere; OQL, overall quality of life.
P.O. da Conceic¸a˜o et al. / Seizure 21 (2012) 583–587586epilepsy services is estimated to be approximately 9%,17 and the
prevalence rates are even higher (19–27%) in specialized centers.18
Despite this high prevalence, patients with this condition have
frequently been excluded (for psychiatric reasons) from a complete
evaluation of their epilepsy syndromes. Some reasons to justify
this attitude are the occurrence of postictal disorders during VEEG,
the possibility of alternative psychosis and postoperative exacer-
bations of preexisting psychosis.6,19,20
Previous studies have suggested that POE recurrence may be
closely linked to seizure exacerbation during VEEG.6,19 The yearly
incidence of postictal psychiatric disorders has been reported as
7.9% among patients with partial epilepsy who undergo VEEG
monitoring, and episodes of PIP represent the majority of these
disorders (6.4%).20 PIP was the only AE observed in the present
study, and it occurred in a slightly higher proportion than had been
reported in previous studies.6,19,20 However, these events did not
alter the length of hospitalization for the two patients who
presented this AE, and neither AE negatively inﬂuenced the post-
surgical outcome of the patients who underwent CAH.
Few studies, however, have adequately addressed the psychiatric
and seizure post-surgical outcomes of patients with preoperative
POE.7,8 Although some studies have reported a post-surgical
remission of psychotic symptoms,20,21 others have concluded that
IIP does not change after surgery, while PIP symptoms may be
diminished and even remitted after patients become free of
disabling seizures.22,23 The possible signiﬁcance of behavioral AEs
during VEEG monitoring and post-surgical psychiatric outcome has
also been a matter of interest in past studies. Kanemoto et al.23
reported preoperative episodes of PIP, left-sided surgeries and auras
of ictal fear as psychopathological risk factors of postoperative mood
disorders. In the present study, all of the PIP patients who underwent
CAH displayed a complete remission of their psychotic symptoms
after surgery. AEs were more likely to be associated with more than
100 tonic–clonic seizures during the patients’ lives and with the
patients’ previous PIP histories. Although a small number of patients
enrolled, the presence of IPI, psychiatric family history, psychic aura,
MTS laterality, interictal foci side and generalization during VEEG
monitoring did not inﬂuence either the occurrence of AEs or the
post-surgical outcomes. In addition, alternative psychoses did not
occur in the psychiatric follow-up evaluations.
Patients with epilepsy have a lower QOL and higher rates of
comorbidities compared with the general population.11 Therefore,
seizure improvement or cessation is of great clinical signiﬁcance forpatients’ QOLeven in the presenceofpersisting psychosis.7,24Surgery
is a better treatment option than prolonged medical therapy for
patientswithrefractoryTLE-MTS.25Inaddition,seizurecontrolcanbe
associated with improvements in the psychiatric condition of PIP
patients.7,8,14 Although signiﬁcant differences were observed only in
the physical health sphere domain, the patients presented important
QOLimprovementsinmost of the ESI-55domainsat the post-surgical
follow-up; such non-signiﬁcant differences could be caused by the
small number of enrolled patients.
To conclude, the present data conﬁrm that VEEG monitoring can
be considered to be a safe procedure for evaluating the possibility of
surgical intervention in patients with refractory TLE-MTS and POE.
Despite the possible occurrence of AEs and the small number of
patients enrolled, we did not observe substantial morbidity or an
increased length of hospitalization in our sample. In addition, the
post-surgical outcome data revealed an overall improvement of
psychotic symptoms and QOL among these patients.
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